Claudio Naranjo was one of the first to experiment with the use of ibogaine in psychotherapy. His pioneering work, conducted in 1967, was the subject of part of his book The Healing Journey. He was the first to consider that ibogaine’s effects are best classified as oneirogenic, or “dream inducing,” to describe it’s effects which are quite distinct from other psychoactives that are used therapeutically. Shortly thereafter, Claudio obtained one of the first patents, issued in France, for the use of ibogaine in psychotherapy.

At the 2016 Global Ibogaine Conference, Claudio will present a closing keynote presentation about his earlier work and the continued development of his psychotherapeutic work since, including newer work that he has conducted with ibogaine.

Register today and join us for this groundbreaking event!